Revolutionary Study Validates Saliva Testing for Circadian Rhythm Monitoring in Surgical Patients

Can Saliva Provide New Insights into Perioperative Care?

Chinese researchers have launched the first multicentre validation study of salivary melatonin and cortisol as non-invasive biomarkers for monitoring circadian rhythm disruptions in surgical patients. The prospective trial at Peking University Third Hospital and Affiliated Tai'an City Central Hospital aims to establish whether saliva can reliably replace blood sampling in perioperative settings, potentially transforming postoperative monitoring and enabling more personalized interventions for patients experiencing circadian disruptions.

The groundbreaking study, registered as ChiCTR2300070470, involves 102 patients undergoing elective neurosurgical and thoracic procedures under general anesthesia. Researchers are conducting simultaneous collection of blood and saliva samples at six-hour intervals during the perioperative period, with strict environmental controls including light exposure limited to below 10 lux during sampling. The primary outcome measures the correlation between peak salivary and plasma melatonin concentrations at 4:00 AM on the first postoperative day, while secondary outcomes analyze rhythm parameters (mesor, amplitude, and acrophase) of both melatonin and cortisol. The study also employs Fitbit Charge 3 wristbands to objectively assess sleep quality, alongside standardized assessments for pain, anxiety, and depression. This comprehensive approach reflects the growing recognition that circadian disruptions significantly impact postoperative recovery and complications. Previous research has demonstrated strong correlations between salivary and plasma melatonin in non-surgical populations, with correlation coefficients ranging from 0.659 to 0.937 across various patient groups, but this relationship remains unexplored in the unique physiological state of the perioperative period, characterized by inflammation, anesthetic effects, and pain. The study protocol incorporates rigorous methodological controls, including standardized light-dark cycles, activity restrictions, and consistent sample collection procedures to minimize confounding variables. "This is the first study to systematically validate salivary biomarkers of circadian rhythm in surgical patients, potentially establishing a practical, non-invasive alternative to repeated blood draws in the postoperative setting," noted the research team in their protocol publication.

Will Non-Invasive Diagnostics Transform Recovery?

The study's outcomes could significantly impact perioperative monitoring practices across global healthcare settings. If salivary melatonin and cortisol prove reliable proxies for plasma measurements, clinicians would gain access to a patient-friendly method for frequent circadian assessments without disrupting sleep or causing additional discomfort through repeated venipuncture. This could be particularly valuable for early identification of patients at risk for circadian-related complications such as postoperative delirium, which affects up to 50% of elderly surgical patients and is strongly linked to circadian rhythm disruptions. The non-invasive nature of saliva collection also makes it ideally suited for integration with emerging digital health technologies and wearable biosensing platforms. Future systems could potentially combine physiological data from consumer-grade wearables with periodic salivary biomarker measurements to create a comprehensive, real-time picture of a patient's circadian health throughout recovery. Such integrated monitoring approaches would enable more targeted chronotherapeutic interventions, such as precisely timed administration of melatonin supplements or strategic light therapy, to actively resynchronize disrupted circadian rhythms. The pharmaceutical industry has shown increasing interest in chronotherapeutics, with several companies developing time-released formulations of existing medications to align with patients' circadian rhythms for improved efficacy and reduced side effects.

What Challenges and Opportunities Lie Ahead?

The study does face several methodological challenges. The researchers acknowledge that their 6-hour sampling intervals might miss shorter ultradian secretory variations in melatonin and cortisol. Additionally, perioperative factors such as fluid restriction, opioid-induced xerostomia, or prolonged fasting could potentially result in insufficient saliva volume for analysis. The research team has implemented specific countermeasures, including optimized perioperative hydration protocols and standardized minimum collection thresholds, but these limitations could impact data completeness. The study's generalizability is also constrained by its exclusion of high-risk patients (ASA physical status IV-V) and shift workers, as well as its focus on specific surgical specialties. Nevertheless, if successful, this validation study could establish the foundation for more widespread implementation of non-invasive circadian monitoring in surgical care, potentially transforming how clinicians assess and manage perioperative rhythmic disruptions. Results from this trial are expected to be published in peer-reviewed journals following completion of data collection and analysis, with potential implications for both clinical practice guidelines and future research directions in perioperative chronobiology.

Industry Context: This study aligns with the growing trend toward non-invasive diagnostics and digital biomarkers in healthcare. The potential validation of salivary melatonin and cortisol for perioperative monitoring represents a significant advancement in patient-centered care technologies, resonating with the broader industry shift toward less invasive monitoring solutions. As pharmaceutical companies increasingly recognize the importance of chronobiology in drug efficacy and safety profiles, validated tools for assessing individual circadian rhythms could accelerate development of personalized chronotherapeutic approaches. This research exemplifies the convergence of traditional biomarker science with digital health technologies, potentially opening new commercial opportunities in the perioperative care space.

Summary

Chinese researchers at Peking University Third Hospital and Affiliated Tai'an City Central Hospital have initiated the first multicentre validation study examining salivary melatonin and cortisol as non-invasive biomarkers for monitoring circadian rhythm disruptions in surgical patients. The prospective trial, registered as ChiCTR2300070470, involves 102 patients undergoing elective neurosurgical and thoracic procedures, with simultaneous collection of blood and saliva samples at six-hour intervals during the perioperative period under strict environmental controls. The study aims to establish whether saliva can reliably replace blood sampling for assessing circadian disruptions, which significantly impact postoperative recovery and complications including delirium affecting up to 50% of elderly surgical patients. Previous research has demonstrated strong correlations between salivary and plasma melatonin in non-surgical populations, but this relationship remains unexplored in the perioperative period characterized by inflammation, anesthetic effects, and pain. The research employs comprehensive methodology including Fitbit Charge 3 wristbands for sleep quality assessment and standardized evaluations for pain, anxiety, and depression. If successful, this validation could transform perioperative monitoring practices by providing a patient-friendly method for frequent circadian assessments without repeated venipuncture, potentially enabling integration with digital health technologies and wearable biosensing platforms for real-time monitoring throughout recovery. The study faces methodological challenges including potential limitations from six-hour sampling intervals that might miss shorter secretory variations and perioperative factors such as opioid-induced xerostomia that could affect saliva volume. Results are expected to establish foundations for widespread implementation of non-invasive circadian monitoring in surgical care and could accelerate development of personalized chronotherapeutic approaches as pharmaceutical companies increasingly recognize the importance of chronobiology in drug efficacy and safety.